Long-term antiviral therapy sustains HBsAg decline, increases HBV RNA negativity and enhances the proportion of patients achieving functional cure in chronic hepatitis B
Long-term antiviral therapy sustains HBsAg decline, increases HBV RNA negativity and enhances the proportion of patients achieving functional cure in chronic hepatitis B. // Annals of Thoracic Surgery Short Reports. – URL: https://www.sciencedirect.com/science/article/pii/S1665268126000335?dgcid=rss_sd_all
Long-term antiviral therapy sustains HBsAg decline, increases HBV RNA negativity and enhances the proportion of patients achieving functional cure in chronic hepatitis B. Annals of Thoracic Surgery Short Reports. https://www.sciencedirect.com/science/article/pii/S1665268126000335?dgcid=rss_sd_all
“Long-term antiviral therapy sustains HBsAg decline, increases HBV RNA negativity and enhances the proportion of patients achieving functional cure in chronic hepatitis B.” Annals of Thoracic Surgery Short Reports.
@article{article3460,
title = {Long-term antiviral therapy sustains HBsAg decline, increases HBV RNA negativity and enhances the proportion of patients achieving functional cure in chronic hepatitis B},
journal = {Annals of Thoracic Surgery Short Reports},
url = {https://www.sciencedirect.com/science/article/pii/S1665268126000335?dgcid=rss_sd_all}
}
Publication date: January–June 2027 Source: Annals of Hepatology, Volume 32, Issue 1 Author(s): Marie Louise N. Therkelsen, Liv Eline Hetland, Mikkel Parsberg Werge, Mira Thing, Elias Badal Rashu, Puria Nabilou, Nina Kimer, Anders...